Patent · US Active

PCNA inhibitors

US10913706B2 · kind B2 · utility

2Cited by
6References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2019
Grant dateFeb 9, 2021
Priority date—
Expiry dateDec 13, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein, inter alia, are compositions of PCNA modulators and methods for treating or preventing cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.